South Korea vs Malaysia: The number of people with susceptibility test result for rifampicin
South Korea
9,284
in 2021
Malaysia
10,434
in 2021
South Korea rank
22nd
Malaysia rank
20th
The number of people with susceptibility test result for rifampicin over time
- South Korea
- Malaysia
How they compare
Malaysia currently reports 10,434 against 9,284 in South Korea, a difference of 1,150.
That makes Malaysia's figure about 1.1 times South Korea's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was South Korea ahead.
South Korea ranks 22nd and Malaysia ranks 20th of 155 countries.
Across the 2 decades both report, South Korea averaged higher in 1 and Malaysia in 1.
Head to head by decade
| Decade | South Korea | Malaysia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 13,475 | 11,620 | 1,855 | South Korea |
| 2020s | 9,936 | 10,381 | 444.5 | Malaysia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, South Korea or Malaysia?
- Malaysia, at 10,434 against 9,284 in South Korea as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between South Korea and Malaysia?
- 1,150, with Malaysia ahead.
- How many years of comparable data are there for South Korea and Malaysia?
- 5 years are reported by both, from 2017 to 2021.
- How do South Korea and Malaysia rank globally for the number of people with susceptibility test result for rifampicin?
- South Korea ranks 22nd and Malaysia ranks 20th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.